Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial
Tuesday, March 5 2024 | 08 h 05 min | Vision Science & Research
Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease Belite Bio, a...
Read MoreVitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa
Wednesday, February 21 2024 | 07 h 53 min | Vision Science & Research
A new study from Dr Eric Pierce and Dr Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for...
Read MoreWhat is Neuro-Optometric Visual Rehabilitation?
Wednesday, April 6 2022 | 13 h 40 min | Optik Magazine, Vision Science & Research
By Dr Patrick Quaid, OD, FCOVD, PhD Full bio: wwwoptiknowca/DrQuaid One could say it is “just Binocular Vision testing” right However,...
Read MoreFirst-of-its-kind Visual Prosthesis Brain Implant Moves to Clinical Trial
Wednesday, July 14 2021 | 09 h 46 min | News, Press Release, Vision Science & Research
While there is currently no cure for blindness, a first-of-its-kind artificial vision system is beginning clinical trials The Intracortical...
Read MoreUsing CRISPR to Treat Glaucoma
Wednesday, March 17 2021 | 08 h 12 min | Vision Science & Research
Researchers from the University of Bristol that are looking for a more long-term treatment option for open angle glaucoma, have turned to gene...
Read More